The company said it needed to raise the money to keep up with demand. Accuri launched its Accuri C6 Flow Cytometer in April 2008 and followed that launch three months later with a $13 million raise to expand its marketing and sales efforts of the product.
CoAxia thinks its NeuroFlo technology could be part of basic care for 500,000 ischemic stroke patients, breaking into a market worth more than $1 billion. Instead of attacking the brain clot, its catheter diverts blood flow from the lower parts of the body and pushes it into the brain to increase blood flow.
Scheduling software is helpful for wellness business owners in numerous ways. They get everything they need to create appointments, reschedule clients and track cancellations in one platform.